Trial intelligence / Profile preview

ROSEMARY: Early Intensive Rosuvastatin in STEMI Patients

NCT01153334Phase 4Completed

Sponsor
Yonsei University
Start
Aug 2010
Primary completion
Jun 2013
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 4 trial of rosuvastatin in ST-segment elevation myocardial infarction (STEMI), sponsored by Yonsei University. Started Aug 2010; status: completed.

02

Drugs

rosuvastatin
03

Conditions

ST-segment elevation myocardial infarction (STEMI)

Beyond the preview

Go deeper on NCT01153334.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01153334.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call